LAG3 Antikörper (Internal Region)
-
- Target Alle LAG3 Antikörper anzeigen
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LAG3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- LAG3 / CD223
- Sequenz
- EDVSQAQAGT YTCH
- Spezifität
- This antibody is expected to recognize the extra-cellular domain.
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Isotyp
- IgG
- Top Product
- Discover our top product LAG3 Primärantikörper
-
-
- Applikationshinweise
-
Western Blot: Approx 55 kDa band observed in Human Lymph Node and Tonsil lysates (calculated MW of 57.4 kDa according to NP_002277.4). Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:2000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Andere Bezeichnung
- LAG3 (LAG3 Produkte)
- Synonyme
- CD223 antikoerper, LAG-3 antikoerper, Ly66 antikoerper, lymphocyte activating 3 antikoerper, lymphocyte-activation gene 3 antikoerper, LAG3 antikoerper, Lag3 antikoerper
- Hintergrund
- LAG3, lymphocyte activating 3, CD223, lymphocyte-activation gene 3
- Gen-ID
- 3902
- NCBI Accession
- NP_002277
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-